Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
|Active Ingredient:||Risdiplam 0.75mg/mL|
|Dosage Form:||Powder for oral solution|
|New Zealand Sponsor:||Roche Products (NZ) Limited|
|Manufacturer:||F Hoffmann-La Roche Limited, Basel, Switzerland|
|Active Ingredients:||Hydrocortisone 1%
Neomycin sulfate 0.35%
|Dosage Form:||Topical ointment|
|New Zealand Sponsor:||LEO Pharma Limited|
|Manufacturers:||Astellas Pharma Europe B.V., Meppel, Netherlands
Temmler Italia S.r.l., Carugate, Italy
Dated this 29th day of March 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).